Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Jun25 Appendix 5B July 14, 2025 Crypto Market Recap: Trump Media Files for Third Crypto ETF, Tether Reveals Gold Holdings July 14, 2025 Company Update – Name Change to ‘American Uranium Limited’ July 14, 2025
Crypto Market Recap: Trump Media Files for Third Crypto ETF, Tether Reveals Gold Holdings July 14, 2025